Top Markets
Coin of the day
AbClon Inc. AbClon Inc.

AbClon Inc.

174900
Rank in Stocks #15850
Founded in Seoul, South Korea, in 2010, AbClon Inc. is a biopharmaceutical... Founded in Seoul, South Korea, in 2010, AbClon Inc. is a biopharmaceutical company engaged in the discovery and development of antibody-based drugs, with operations spanning South Korea and Sweden. The firm's developmental pipeline encompasses therapies derived from distinct technological platforms: the NEST platform addresses breast and gastric cancers; the AffiMab platform targets colon cancer and various autoimmune conditions; and the CAR-T platform is engineered for hematologic and ovarian cancers.
Share Price
$16.42
Market Cap
$327.24M
Change (1 day)
-3.46%
Change (1 year)
129.62%
Country
KR
Trade AbClon Inc. (174900)

Category

Number of shares outstanding for AbClon Inc. (174900)
Number of shares outstanding as of September 2026: 0
According to AbClon Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of September 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for AbClon Inc. (174900) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M -
US
62.19M -
NL
396.00M -
US
478.91M -
AU
- -
CH